×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Mammen Mathai

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
TXG10x Genomics, Inc.Mammen MathaiDirectorMay 11, 2023Option Exercise$8.48233,0001,975,086202,745May 15, 2023, 04:37 PM
JNJJOHNSON & JOHNSONMammen MathaiEVP, Pharm, R&DFeb 15, 2022Option Exercise$165.893,366558,38641,934Feb 17, 2022, 06:00 AM
JNJJOHNSON & JOHNSONMammen MathaiEVP, Pharm, R&DFeb 14, 2022Option Exercise$168.852,335394,26537,560Feb 15, 2022, 08:03 PM
TBPHTheravance Biopharma, Inc.Mammen MathaiSVP, Research & DevelopmentFeb 20, 2016Option Exercise$15.6519,844310,559198,111Feb 23, 2016, 07:58 PM
TBPHTheravance Biopharma, Inc.Mammen MathaiSVP, Research & DevelopmentNov 20, 2015Option Exercise$17.1793416,037217,955Nov 24, 2015, 07:37 PM
TBPHTheravance Biopharma, Inc.Mammen MathaiSVP, Research & DevelopmentAug 20, 2015Option Exercise$12.9893412,123218,889Aug 24, 2015, 07:11 PM
TBPHTheravance Biopharma, Inc.Mammen MathaiSVP, Research & DevelopmentJun 02, 2015Option Exercise$13.837,360101,789219,823Jun 04, 2015, 07:14 PM
TBPHTheravance Biopharma, Inc.Mammen MathaiSVP, Research & DevelopmentMay 20, 2015Option Exercise$14.246739,584227,183May 22, 2015, 07:13 PM
TBPHTheravance Biopharma, Inc.Mammen MathaiSVP, Research & DevelopmentFeb 20, 2015Option Exercise$19.5267413,156227,856Feb 24, 2015, 06:55 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevAug 20, 2014Option Exercise$22.763,26174,220334,040Aug 22, 2014, 05:02 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevMay 09, 2014Option Exercise$26.8622,833613,294239,136May 12, 2014, 07:13 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevMar 06, 2014Option Exercise$14.9042,153627,997224,469Mar 10, 2014, 07:06 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevFeb 20, 2014Option Exercise$39.984,307172,194182,316Feb 24, 2014, 07:11 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevFeb 14, 2014Sale$39.3635,0001,377,688191,223Feb 19, 2014, 07:13 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevNov 20, 2013Option Exercise$36.404,569166,312222,073Nov 22, 2013, 07:02 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevAug 20, 2013Option Exercise$35.893,813136,849207,892Aug 22, 2013, 07:02 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevAug 21, 2013Option Exercise$16.0018,750300,000226,642Aug 22, 2013, 07:02 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevJul 30, 2013Sale$36.517,000255,570211,705Aug 01, 2013, 05:33 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevMay 29, 2013Option Exercise$8.5411,02194,159213,705May 31, 2013, 07:03 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevMay 20, 2013Option Exercise$37.013,292121,837202,684May 22, 2013, 06:55 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevApr 30, 2013Sale$33.747,000236,164206,176May 02, 2013, 07:06 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevFeb 20, 2013Sale$22.1212,002265,524219,976Feb 22, 2013, 07:03 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevJan 11, 2013Option Exercise$3.1014,51044,981220,438Jan 14, 2013, 07:04 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevNov 20, 2012Option Exercise$21.084,874102,744205,928Nov 20, 2012, 07:05 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevNov 14, 2012Option Exercise$3.105,16115,999210,802Nov 16, 2012, 07:01 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevNov 02, 2012Sale$21.457,000150,162205,841Nov 06, 2012, 07:01 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevAug 20, 2012Option Exercise$27.014,644125,434207,641Aug 22, 2012, 07:03 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevAug 13, 2012Sale$25.7425,000643,461215,393Aug 15, 2012, 07:05 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevMay 20, 2012Option Exercise$20.333,83277,905237,285May 22, 2012, 07:21 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevFeb 20, 2012Option Exercise$18.549,747180,709241,117Feb 22, 2012, 07:03 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevNov 20, 2011Option Exercise$22.342,25050,265245,864Nov 22, 2011, 07:05 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevSep 01, 2011Option Exercise$8.523,22527,493248,114Sep 02, 2011, 06:02 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevAug 20, 2011Option Exercise$17.502,24839,340244,889Aug 24, 2011, 04:23 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevMay 20, 2011Option Exercise$25.482,24557,203247,137May 24, 2011, 07:08 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevFeb 18, 2011Sale$23.123,70185,567252,622Feb 23, 2011, 07:11 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevFeb 20, 2011Option Exercise$22.503,24072,900249,382Feb 23, 2011, 07:11 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevJan 28, 2011Option Exercise$8.529,83883,869143,823Jan 28, 2011, 07:01 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevNov 20, 2010Option Exercise$22.522,53257,021133,985Nov 23, 2010, 07:01 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevSep 07, 2010Option Exercise$8.526,45154,995124,017Sep 08, 2010, 07:15 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevSep 01, 2010Sale$12.844,41656,701117,566Sep 02, 2010, 07:09 PM
THRXTHERAVANCE INCMammen MathaiSVP, Research & Early Clin DevAug 20, 2010Option Exercise$14.001,67123,394121,982Aug 23, 2010, 07:01 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe